Introduction Semaglutide, a medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://andresquxad.wikicorrespondence.com/4158269/semaglutide_a_breakthrough_in_managing_diabetes_weight_and_heart_health